Perfect Origins LLC – Trademark Portfolio

Entity Type: 16

Perfect Origins LLC holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 12 filings in this category. The portfolio also extends into Class 24 (Fabrics) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include LIVLEAN, PERFECT EFA, VIVE BIOTICS, and PERFECT FLUSH. The owner is based in Carmel, IN.

1950 E Greyhound Pass Ste 18-344

Carmel, IN 46033

13 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Perfect Origins LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (12 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

24
Fabrics (1 filing)

Textiles and textile goods; bed covers; table covers

Frequently Asked Questions

How many trademarks does Perfect Origins LLC have?

Perfect Origins LLC has 13 U.S. trademarks filed with the USPTO. Of these, 4 registered, 3 abandoned, 6 cancelled.

What trademark classes does Perfect Origins LLC file in?

Perfect Origins LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 24 (Fabrics). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Perfect Origins LLC's most well-known trademarks?

Perfect Origins LLC's registered trademark portfolio includes well-known marks such as LIVLEAN, PERFECT EFA, VIVE BIOTICS, and PERFECT FLUSH. These are among 4 currently registered trademarks in the portfolio.

What is Perfect Origins LLC's trademark registration success rate?

Perfect Origins LLC has a 31% trademark registration rate, with 4 out of 13 resolved applications resulting in successful registration. Currently, 0 applications are pending review.